OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariants
Jimena Pérez‐Vargas, L.J. Worrall, Andrea Olmstead, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 9

Showing 9 citing articles:

On the origins of SARS-CoV-2 main protease inhibitors
Yves L. Janin
RSC Medicinal Chemistry (2023) Vol. 15, Iss. 1, pp. 81-118
Closed Access | Times Cited: 15

Kinetic comparison of all eleven viral polyprotein cleavage site processing events by SARS-CoV-2 Main Protease using a linked protein FRET platform
Calem Kenward, M. Vuckovic, Mark Paetzel, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 6, pp. 107367-107367
Open Access | Times Cited: 6

Non-peptidic inhibitors targeting SARS-CoV-2 main protease: A review
Ya-Qi Xiao, Jiao Long, Shuang‐Shuang Zhang, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107380-107380
Closed Access | Times Cited: 5

Revisiting the potential of natural antimicrobial peptides against emerging respiratory viral disease: a review
Neelakanta Sarvashiva Kiran, Sudarshan Singh, Chandrashekar Yashaswini, et al.
3 Biotech (2025) Vol. 15, Iss. 2
Closed Access

Potential Broad-Spectrum Antiviral Agents: A Key Arsenal Against Newly Emerging and Reemerging Respiratory RNA Viruses
Quynh Xuan Thi Luong, Phuong Thi Hoang, Phuong T. Ho, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1481-1481
Open Access

Nanomolar anti-SARS-CoV-2 Omicron activity of the host-directed TMPRSS2 inhibitor N-0385 and synergistic action with direct-acting antivirals
Jimena Pérez‐Vargas, Gabriel Lemieux, Connor A.H. Thompson, et al.
Antiviral Research (2024) Vol. 225, pp. 105869-105869
Open Access | Times Cited: 4

Progress in Research on Inhibitors Targeting SARS-CoV-2 Main Protease (Mpro)
Yue Yang, Yidan Luo, Chenbo Zhang, et al.
ACS Omega (2024) Vol. 9, Iss. 32, pp. 34196-34219
Open Access | Times Cited: 3

Crystal structures of coronaviral main proteases in complex with the non-covalent inhibitor X77
Haihai Jiang, Wen Li, Xuelan Zhou, et al.
International Journal of Biological Macromolecules (2024) Vol. 276, pp. 133706-133706
Closed Access | Times Cited: 2

REVISITING THE SARS-COV-2 MAIN PROTEASE: A 2023 IN SILICO ODYSSEY IN SEARCH OF POTENTIAL INHIBITORS
Chenyue Fan, Ayesha Abdul Qadir Memon, Prajit Adhikari, et al.
Journal of Population Therapeutics and Clinical Pharmacology (2023), pp. 1032-1049
Open Access | Times Cited: 1

Page 1

Scroll to top